Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Implicity raises €35M from IRIS and Five Arrows for AI cardiac monitoring platform that reduces patient mortality by 26%.
PRIVATESep 09, 2026•about 4 hours ago
Amount Raised
€35 Million
Round Type
Venture - Series Unknown
CambridgeBiotechnologySoftwareData And AnalyticsHealth CareScience And EngineeringArtificial Intelligence
Investors
Five ArrowsIris
Description
Implicity has secured €35 million in growth funding led by IRIS and Five Arrows to expand its AI-powered cardiac monitoring platform. The company's technology has achieved a 26% reduction in patient mortality for cardiac device monitoring. Implicity plans to use the funds to accelerate expansion in the United States and pursue strategic acquisitions. The company, founded by Dr
Company Information
Company
IMPLICITY
Location
Cambridge, Maryland, United States
About
Implicity® is a digital MedTech company - founded by cardiac electrophysiologist Arnaud Rosier MD - that provides a universal cardiac remote monitoring and research platform to hospitals and clinics - helping them provide the best remote care to cardiac patients.
Implicity develops unique AI and knowledge-based algorithms with the potential to predict patient health status, reducing healthcare professionals' workload.
The Implicity platform aggregates, normalizes, and standardizes data from all implantable cardiac electronic devices across all major manufacturers - and improves care for patients with chronic heart failure conditions. Implicity proudly protects over 80,000 patients in more than 150 medical facilities across the United States and Europe.
www.implicity.com
Don't miss IMPLICITY's next move
Get an email the moment IMPLICITY raises, hires an exec, or expands, usually minutes after it happens.
CambridgeBiotechnologySoftwareData And AnalyticsHealth CareScience And EngineeringArtificial Intelligence